Pembrolizumab in Combination with Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM)

被引：7
|
作者：
Badros, Ashraf Z. [1 ]
Hyjek, Elizabeth [2 ]
Ma, Ning [1 ]
Lesokhin, Alexander M. [3 ]
Rapoport, Aaron P. [1 ]
Kocoglu, Mehmet H. [1 ]
Lederer, Emily [4 ]
Philip, Sunita [4 ]
Lesho, Patricia [4 ]
Johnson, Ashlee [4 ]
Dell, Cameron [4 ]
Goloubeva, Olga [4 ]
Singh, Zeba [5 ]
机构：
[1] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD USA
[2] Univ Chicago, Dept Pathol, Chicago, IL USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Div Hematol Oncol, Myeloma Serv, New York, NY USA
[4] Univ Maryland, Baltimore, MD USA
[5] Univ Maryland, Sch Med, Pathol, Baltimore, MD USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.490.490
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
490
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma
    Shah, Jatin J.
    Stadtmauer, Edward A.
    Abonour, Rafat
    Cohen, Adam D.
    Bensinger, William I.
    Gasparetto, Cristina
    Kaufman, Jonathan L.
    Lentzsch, Suzanne
    Vogl, Dan T.
    Gomes, Christina L.
    Pascucci, Natalia
    Smith, David D.
    Orlowski, Robert Z.
    Durie, Brian G. M.
    BLOOD, 2015, 126 (20) : 2284 - 2290
  • [32] Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma
    Hussain, M. Junaid
    Robinson, Myra M.
    Hamadeh, Issam
    Arnall, Justin
    Bhutani, Manisha
    Atrash, Shebli
    Friend, Reed
    Pineda-Roman, Mauricio
    Symanowski, James T.
    Usmani, Saad Z.
    Voorhees, Peter M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (01) : 140 - 144
  • [33] Clapd (Clarithromycin, Pomalidomide, Dexamethasone) Therapy In Relapsed Or Refractory Multiple Myeloma
    Mark, Tomer M.
    Boyer, Angelique
    Rossi, Adriana C.
    Kwon, Dennis
    Pearse, Roger N.
    Zafar, Faiza
    Pekle, Karen
    Tegnestam, Linda
    Jayabalan, David
    Ely, Scott A.
    Coleman, Morton
    Chen-Kiang, Selina
    Niesvizky, Ruben
    BLOOD, 2013, 122 (21)
  • [34] ClaPD (Clarithromycin, Pomalidomide, Dexamethasone) Therapy in Relapsed or Refractory Multiple Myeloma
    Mark, Tomer M.
    Boyer, Angelique
    Rossi, Adriana C.
    Shah, Manan
    Pearse, Roger N.
    Zafar, Faiza
    Pekle, Karen
    Tegnestam, Linda
    Sacris, Erlinda A.
    Greenberg, June
    Speaker, Stephanie
    Jayabalan, David
    Ely, Scott A.
    Coleman, Morton
    Chen-Kiang, Selina
    Niesvizky, Ruben
    BLOOD, 2012, 120 (21)
  • [35] A phase I/II study of Pomalidomide, Ixazomib, Clarithromycin and Dexamethasone (PICd) in patients with relapsed or refractory Multiple Myeloma (RRMM)
    Rosenberg, Aaron
    Munoz, Meilen
    Costello, Caitlin
    Brem, Elizabeth
    Reid, Erin
    Maverakis, Emanual
    Kaesberg, Paul
    Lee, Lisa
    Abedi, Mehrdad
    Tuscano, Joseph
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S157 - S158
  • [36] Clarithromycin, pomalidomide, and dexamethasone (ClaPD) in relapsed or refractory multiple myeloma.
    Rossi, Adriana C.
    Mark, Tomer Martin
    Rodriguez, Melissa
    Shah, Manan
    Quinn, Ryann
    Pearse, Roger N.
    Zafar, Faiza
    Pekle, Karen
    Speaker, Stephanie
    Jayabalan, David
    Ely, Scott
    Coleman, Morton
    Chen-Kiang, Selina
    Niesvizky, Ruben
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] Pomalidomide in combination with dexamethasone approved for use in refractory multiple myeloma
    Brown, Emily
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2013, 2 (06) : 516 - 517
  • [38] Selinexor, Pomalidomide, and Dexamethasone (SPd) in Patients with Relapsed or Refractory Multiple Myeloma
    Chen, Christine I.
    Bahlis, Nizar
    Gasparetto, Cristina
    Tuchman, Sascha A.
    Lipe, Brea C.
    Baljevic, Muhamed
    Kotb, Rami
    Sutherland, Heather J.
    Bensinger, William I.
    Sebag, Michael
    Leblanc, Richard
    Venner, Christopher P.
    Schiller, Gary J.
    Lentzsch, Suzanne
    Callander, Natalie Scott
    Sheehan, Heidi
    Chai, Yi
    Kai, Kazuharu
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    White, Darrell J.
    BLOOD, 2019, 134
  • [39] Elotuzumab in Combination with Pomalidomide and Corticosteroids for Relapsed or Refractory Multiple Myeloma
    Sidiqi, Hasib
    McGregor, Scott
    Baker, Ross
    Carnley, Ben
    Radeski, Dejan
    Barraclough, Allison
    Augustson, Bradley
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E83 - E84
  • [40] a Phase 1/2 Trial of Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    Berenson, James
    Stampleman, Laura
    Bessudo, Alberto
    Rosen, Peter J.
    Klein, Leonard M.
    Woliver, Thomas
    Flam, Marshall S.
    Eshaghian, Shahrooz
    Nassir, Youram
    Regina, Swift A.
    James, Wang
    Benjamin, Eades
    Spektor, Tanya M.
    Vescio, Robert
    BLOOD, 2015, 126 (23)
12345